These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10466441

  • 1. Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
    Meidlinger P, Knöbl P, Jäger U, Gisslinger H, Pabinger I, Weltermann A, Lechner K, Geissler K.
    Ann Hematol; 1999 Jul; 78(7):299-304. PubMed ID: 10466441
    [Abstract] [Full Text] [Related]

  • 2. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, Sica S, Varotto S, Arcese W, Locatelli F, Soligo D, Bacigalupo A, GITMO prospective randomized study.
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
    Kanakura M, Mihara H, Wakabayashi M, Tajima E, Hiramatsu A, Sato A, Imamura A, Miwa H, Kato Y, Nitta M.
    Nihon Naika Gakkai Zasshi; 2002 Mar 10; 91(3):1036-8. PubMed ID: 11985078
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin.
    Frickhofen N, Heit W, Raghavachar A, Porzsolt F, Heimpel H.
    Klin Wochenschr; 1986 Nov 17; 64(22):1165-70. PubMed ID: 3492629
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
    Matsuo Y, Iwanaga M, Mori H, Yoshida S, Kawaguchi Y, Yakata Y, Murata K, Nagai K, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M.
    Int J Hematol; 2000 Jul 17; 72(1):37-43. PubMed ID: 10979207
    [Abstract] [Full Text] [Related]

  • 20. Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia.
    Raghavachar A, Ganser A, Freund M, Heimpel H, Herrmann F, Schrezenmeier H.
    Cytokines Mol Ther; 1996 Dec 17; 2(4):215-23. PubMed ID: 9384707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.